Key result
PBMV rapidly cuts pulmonary artery pressure by ~37 mmHg within 48 hours.
Why the study?
Pulmonary hypertension and functional TR are important right-sided consequences of severe rheumatic mitral stenosis that may respond rapidly to relief of mitral obstruction. This study aimed to assess early changes in pulmonary artery pressure, TR severity, and conventional RV structure and systolic function after PBMV.
Does percutaneous balloon mitral valvuloplasty improve early pulmonary artery pressure, tricuspid regurgitation severity, and right ventricular systolic function in adults with severe rheumatic mitral stenosis?
Cohort (n=50)
Does percutaneous balloon mitral valvuloplasty improve early pulmonary artery pressure, tricuspid regurgitation severity, and right ventricular systolic function in adults with severe rheumatic mitral stenosis?
Answers are grounded in this paper and cite their sources.
Percutaneous balloon mitral valvuloplasty in severe rheumatic mitral stenosis produces rapid within-48-hour reductions in pulmonary artery pressure and functional tricuspid regurgitation alongside improved right ventricular systolic indices.
Background: Pulmonary hypertension and functional tricuspid regurgitation (TR) are important right-sided consequences of severe rheumatic mitral stenosis and may respond rapidly to relief of mitral obstruction. This study aimed to assess early changes in pulmonary artery pressure, TR severity, and conventional right ventricular (RV) structure and systolic function after percutaneous balloon mitral valvuloplasty (PBMV). Patients and Methods: This secondary analysis of a prospective pre-post cohort included 50 adults with severe rheumatic mitral stenosis. Transthoracic echocardiography was performed within 24 hours before PBMV and repeated within 48 hours after the procedure. Paired changes in mitral valve hemodynamics, pulmonary artery pressure, RV diameter, fractional area change (FAC), tricuspid annular plane systolic excursion (TAPSE), and TR severity were evaluated. Results: Mean age was 33.3 +/- 4.8 years and 82% were women. Mean transmitral gradient decreased from 16.7 +/- 6.1 to 6.3 +/- 2.2 mmHg, while 3D mitral valve area increased from 1.0 +/- 0.2 to 2.2 +/- 0.2 cm2. Pulmonary artery pressure fell from 65.9 +/- 11.1 to 28.5 +/- 6.6 mmHg. RV diameter decreased from 44.7 +/- 3.8 to 41.5 +/- 3.9 mm, FAC increased from 39.2 +/- 5.7% to 50.2 +/- 5.0%, and TAPSE increased from 17.7 +/- 3.5 to 22.8 +/- 2.4 mm (all p<0.001). Moderate TR decreased from 32% to 4%, whereas trivial TR increased from 10% to 80% (p<0.001). Conclusion: PBMV was associated with marked early pulmonary and right-heart unloading, with rapid improvement in TR severity and conventional RV systolic indices. Longer follow-up is required to determine the durability and prognostic significance of these early changes.
No takes yet. Share an insight, caveat, or question.
Abdel-Aal et al. (2026) conducted a cohort in Severe rheumatic mitral stenosis (n=50). Percutaneous balloon mitral valvuloplasty (PBMV) vs. Pre-procedure baseline (within 24 hours before PBMV) was evaluated on Early changes in pulmonary artery pressure, tricuspid regurgitation (TR) severity, and conventional right ventricular (RV) structure and systolic function (p=<0.001). Percutaneous balloon mitral valvuloplasty reduced pulmonary artery pressure from 65.9 to 28.5 mmHg and moderate TR from 32% to 4% within 48 hours.
Synapse has enriched 10 related papers. Consider them for comparative context: